Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Single- and multiple-dose clinical studies reported for SL-91.0102

Oct. 1, 1997

New treatment for ISH evaluated in humans

Oct. 1, 1997

Na+/K+-exchange inhibitors from Fujisawa

Sep. 30, 1997

Clinical pharmacokinetics and bradycardic activity of S-16257

Sep. 30, 1997

Mechanism of action revealed for Theratechnologies' Protectazem

Sep. 29, 1997

Endothelin agonists/antagonists from Texas Biotechnology

Sep. 29, 1997

New Na+/H+-exchange inhibitors from Fujisawa

Sep. 26, 1997

FDA grants final marketing approval for Corlopam

Sep. 25, 1997

Irbesartan introduced in first markets

Sep. 25, 1997

VasoCare reduces stress in animal model of hypertension

Sep. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...